Visipaque
Generic name: Iodixanol
Drug class:
Non-ionic iodinated contrast media
Usage of Visipaque
Visipaque is in a group of drugs called radiopaque (RAY dee oh payk) contrast agents. This medicine contains iodine, a substance that absorbs x-rays. Radiopaque contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination.
Visipaque is used to help diagnose certain disorders of the brain, blood vessels, heart, kidneys, and other internal organs.
Visipaque may also be used for purposes not listed in this medication guide.
Visipaque side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).
Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include: skin rash, fever, swollen glands, flu-like symptoms, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes.
Visipaque may cause serious side effects. Call your doctor at once if you have:
Common side effects of Visipaque may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Visipaque
Visipaque should not be given to a child who has recently used a laxative (stool softener) or has not eaten properly.
Tell your doctor if you have ever had any type of reaction to another contrast agent.
To make sure Visipaque is safe for you, tell your doctor if you have:
It is not known whether Visipaque will harm an unborn baby. Tell your doctor if you are pregnant.
It is not known whether iodixanol passes into breast milk or if it could affect the nursing baby. You should not breast-feed within 10 hours after receiving iodixanol. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.
Relate drugs
- Iodixanol
- Iohexol (Injection, Intrathecal, Intravenous)
- Iohexol (Oral)
- Iopamidol
- Iopromide
- Ioversol
- Isovue-200
- Isovue-250
- Isovue-300
- Isovue-370
- Isovue-M-200
- Isovue-M-300
- Omnipaque 12
- Omnipaque 140
- Omnipaque 180
- Omnipaque 240
- Omnipaque 300
- Omnipaque 350
- Omnipaque 9
- Omnipaque Flexipak
- Optiray 160
- Optiray 240
- Optiray 300
- Optiray 320
- Optiray 350
- Oraltag
- Ultravist
- Visipaque
How to use Visipaque
Visipaque is injected into a vein through an IV. A healthcare provider will give you this injection just before your radiologic test.
You may be given medication to prevent certain side effects while you are receiving Visipaque.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Visipaque is injected.
Drink extra fluids before and after your radiologic test. Visipaque can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test.
Older adults may need special care to avoid becoming dehydrated. Your kidney function may need to be checked after you have received Visipaque.
Visipaque can interfere with certain medical tests for up to 16 days after you are treated with this medicine. Tell any doctor who treats you that you have recently received this medicine.
Visipaque can make radioactive iodine less effective in people with thyroid cancer. This effect can last for up to 8 weeks after you receive this medicine. Tell your doctor if you are scheduled to be treated with radioactive iodine I-131 or I-123.
Warnings
Visipaque should not be given to a child who has recently used a laxative (stool softener) or has not eaten properly.
What other drugs will affect Visipaque
Tell your doctor about all your current medicines, especially:
This list is not complete. Other drugs may interact with iodixanol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions